The Society for Immunotherapy of Cancer (SITC) hosted the “Workshop on Engineering Immune Cells for Cancer Therapy” during the 35th Anniversary Annual Meeting & Pre-Conference Programs on November 9, 2020. Available here are the presentation slides and video from “Session 1: Advances in Adoptive T cell Therapy for Cancer: TILs and TCRs,” as permitted by presenters.
Program Summary
CAR T treatments have led to improved outcomes for patients with hematologic malignancies. However, the same level of success has not been achieved in most solid tumors, and other immune cell types beyond T cells are also being explored preclinically and clinically. This workshop highlighted the multitude of cellular therapy approaches being applied for the treatment of cancer, including many T cell strategies, alternative immune cells, practical considerations and novel technologies.
Program Organizers
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: Workshop on Engineering Immune Cells for Cancer Therapy; Session I: Advances in Adoptive T cell Therapy for Cancer: TILs and TCRs; Presenter: John Haanen, MD, PhD – Netherlands Cancer Institute; Date: November 9, 202000:20:03
Meeting: Workshop on Engineering Immune Cells for Cancer Therapy; Session I: Advances in Adoptive T cell Therapy for Cancer: TILs and TCRs; Presenter: Steven A. Rosenberg, MD, PhD – National Cancer Institute, National Institutes of Health ; Date: November 9, 202000:20:46
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us